Anthropic has launched Claude for Healthcare, a suite of AI tools for health systems, payers, and patients, in the latest ...

The US regulator has approved Sentynl Therapeutics Zycubo (copper histidinate; formerly known as CUTX-101) as a treatment for ...

AbbVie has joined many of its big pharma peers by signing a most-favoured nation (MFN) drug pricing deal with the Trump ...

The data was revealed as a UK delegation headed by MHRA chief executive Lawrence Tallon attended the J PM Healthcare ...

Laboratories are no longer peripheral. They are central to modern clinical development - enabling earlier decision-making, ...

Global chipmaker giant NVIDIA kicked off JPM Week with several partnership announcements, most notably a billion dollar ...

The licensing agreement, which includes a big upfront payment of $650 million and milestone payments of up to $4.95 billion, ...

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

Jiangsu Hengrui Pharma has chalked up a first-in-class approval for retlirafusp alfa, a bifunctional drug that targets PD-L1 and TGF-beta, as a treatment for advanced gastric cancer. The green light – ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly's radar after ...

Madrigal Pharma is reheating a drug for metabolic dysfunction-associated steatohepatitis (MASH) put on ice by Pfizer, hoping ...